Friday, November 15, 2013

Religare Health Trust: Results in line, acquisition in sight (CIMB)

Religare Health Trust
Current S$0.80
Target S$0.93
Results in line, acquisition in sight

▊ 2QFY14 results were largely in line. Underlying revenue growth was weighed down by rupee depreciation, which remains the key risk for RHT. The potential acquisition of the Mohali Clinical Establishment is noteworthy but inconclusive given the lack of details. At 50% of our FY13/14 forecast, 1H DPU broadly met our and consensus expectations. Our DDM-based target price (discount rate of 11.7%) remains at S$0.93 after we fine-tune FY14-16 DPUs. We maintain our Outperform rating, with catalysts coming from acquisitions and earnings delivery.

 
Improved performance in Rupee terms
Net service fee and hospital income in rupee terms rose 4.3% qoq, largely caused by higher variable fee and hospital income. Much of this was attributable to the summer months, which brought common communicable diseases such as dengue fever which requires longer stays but is a low income-generating disease. This raised the occupancy rate to 86% but reduced ARPOB by 2.4%, increasing variable fee and hospital income by c.8%.  
 
Rupee concern weighs
Rupee weakness remains one of the key risks for RHT. Factoring in the rupee depreciation, net service fee and hospital income declined 5.3% qoq. RHT maintains its policy of hedging two distributions on a 1-year forward basis. The average contracted hedging rate for FY14 is Rs47.28:S$1. With the current exchange rate at Rs50:S$1 and the hedging premium rising, we expect earnings to experience continued pressure from the weakening rupee.  
 
Acquisition in the horizon
Management is in discussions to acquire the Mohali Clinical Establishment, located in Punjab, India and operated by Fortis Healthcare. This is a stable asset with 12 years of operating record. It is Fortis’s second largest hospital by FY12-13 revenue. There should be greater clarity in the next 3-4 months.


Source/Extract/Excerpts/来源/转贴/摘录: CIMB-Research,
Publish date:13/11/13

No comments:

Post a Comment

Warren E. Buffett(沃伦•巴菲特)
Be fearful when others are greedy, and be greedy when others are fearful
别人贪婪时我恐惧, 别人恐惧时我贪婪
投资只需学好两门课: 一,是如何给企业估值,二,是如何看待股市波动
吉姆·罗杰斯(Jim Rogers)
“错过时机”胜于“搞错对象”:不会全军覆没!”
做自己熟悉的事,等到发现大好机会才投钱下去

乔治·索罗斯(George Soros)

“犯错误并没有什么好羞耻的,只有知错不改才是耻辱。”

如果操作过量,即使对市场判断正确,仍会一败涂地。

李驰(中国巴菲特)
高估期间, 卖对, 不卖也对, 买是错的。
低估期间, 买对, 不买也是对, 卖是错的。

Tan Teng Boo


There’s no such thing as defensive stocks.Every stock can be defensive depending on what price you pay for it and what value you get,
冷眼(冯时能)投资概念
“买股票就是买公司的股份,买股份就是与陌生人合股做生意”。
合股做生意,则公司股份的业绩高于一切,而股票的价值决定于盈利。
价值是本,价格是末,故公司比股市重要百倍。
曹仁超-香港股神/港股明灯
1.有智慧,不如趁势
2.止损不止盈
成功者所以成功,是因为不怕失败!失败者所以失败,是失败后不再尝试!
曾淵滄-散户明灯
每逢灾难就是机会,而是在灾难发生时贱价买股票,然后放在一边,耐性地等灾难结束
  • Selected Indexes 52 week range

  • Margin of Safety

    Investment Clock

    World's First Interactive Investment Clock